Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer

Clinical trial NCT07064876 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07064876
Sponsor: Xi Junjie
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early Lung Cancer

Start date: 2025-10-01
Primary completion: 2026-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.